Cyclosporine-A enhances choline acetyltransferase immunoreactivity in the septal region of adult rats

Neuroscience Letters

Volumn 279, Issue 2, 2000, Pages 73-76

  Borlongan, Cesario V ^a   Stahl, Christine E ^b   Keep, Marcus F ^c,d   Elmér, Eskil ^c,d,e   Watanabe, Shigeru ^f  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b WILLIAM BEAUMONT ARMY MEDICAL CENTER   (United States)

^c Maas BiolAB   (United States)

^d UNIVERSITY OF HAWAII   (United States)

^e Department of Clinical Neuroscience   (Sweden)

^f KEIO UNIVERSITY   (Japan)

Author keywords

Alzheimer's disease; Calcineurin; Cholinergic system; Immunosuppression; Mitochondrial permeability transition pore; Neurotrophic effects; Septum

Indexed keywords

CALCINEURIN; CHOLINE ACETYLTRANSFERASE; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; CHANNEL GATING; CHOLINERGIC SYSTEM; CONTROLLED STUDY; DRUG EFFECT; FEMALE; IMMUNOREACTIVITY; MEMBRANE PERMEABILITY; MITOCHONDRIAL MEMBRANE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SEPTUM NUCLEUS;

ANIMALS; CHOLINE O-ACETYLTRANSFERASE; CYCLOSPORINE; FEMALE; IMMUNOHISTOCHEMISTRY; RATS; RATS, WISTAR; SEPTUM OF BRAIN;

EID: 0033977759     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(99)00962-3     Document Type: Article

References (20)

1. Bakay R.A.E., Boyer K.L., Freed C.R., Ansari A.A. Immunological response to injury and grafting in the central nervous system of nonhuman primates. Cell Transplant. 7:1998;109-120.
2. Borlongan C.V., Kwanbara Y., Fujisaki T., Watanabe S. Cyclosporine-A reduces spontaneous place preference in adult rats. Neurosci. Lett. 267:1999;169-172.
3. Borlongan C.V., Stahl C.E., Fujisaki T., Sanberg P.R., Watanabe S. Cyclosporine A-induced hyperactivity in rats: is it mediated by immunosuppression, neurotrophism, or both? Cell Transplant. 8:1999;153-159.
4. Borlongan C.V., Fujisaki T., Watanabe S. Chronic administration of Cyclosporine-A does not impair memory retention in rats. NeuroReport. 8:1997;673-676.
5. Borlongan C.V., Stahl C.E., Cameron D., Saporta S., Freeman T.B., Cahill D.W., Sanberg P.R. CNS immunological modulation of neural graft rejection and survival. Neurol. Res. 18:1996;297-304.
6. Brundin P., Widner H., Nilsson O.G., Strecker R.E., Björklund A. Intracerebral xenografts of dopamine neurons: the role of immunosuppression and the blood-brain barrier. Exp. Brain Res. 75:1989;195-207.
7. Butcher S.P., Henshall D.C., Teramura Y., Iwasaki K., Sharkey J. Neuroprotective actions of FK506 in experimental stroke: in vivo evidence against an antiexcitotoxic mechanism. J. Neurosci. 17:1997;6939-6946.
8. Friberg H., Ferrand-Drake M., Bengtsson F., Halestrap A.P., Wieloch T. Cyclosporin A, but not FK 506, protects mitochondria and neurons against hypoglycemic damage and implicates the mitochondrial permeability transition in cell death. J. Neurosci. 18:1998;5151-5159.
9. Goto S., Hirano A. Calcineurin in the postnatal striatum of the rat: an immunohistochemical study. Exp. Brain Res. 77:1989;442-446.
10. Kitamura Y., Itano Y., Kubo T., Nomura Y. Suppressive effect of FK-506, a novel immunosuppressant, against MPTP-induced dopamine depletion in the striatum of young C57BL/6 mice. J. Neuroimmunol. 50:1994;221-224.
11. Kruman I.I., Mattson M.P. Pivotal role of mitochondrial calcium uptake in neural cell apoptosis and necrosis. J. Neurochem. 72:1999;529-540.
12. Lemasters J.J. Necrapoptosis and the mitochondrial permeability transition: shared pathways to necrosis and apoptosis. Am. J. Physiol. 276:1999;1-6.
13. Matsuura K., Makino H., Ogawa N. Cyclosporin A attenuates the decrease in tyrosine hydroxylase immunoreactivity in nigrostriatal dopaminergic neurons and in striatal dopamine content in rats with intrastriatal injection of 6-hydroxydopamine. Exp. Neurol. 146:1997;526-535.
14. Morioka M., Hamada J., Ushio Y., Miyamoto E. Potential role of calcineurin for brain ischemia and traumatic injury. Prog. Neurobiol. 58:1999;1-30.
15. Oyanagui Y. Immunosuppressants and TGF-beta 1 accelerated and prolonged the nitric oxide/oxyradicals-dependent suppression by dexamethasone in paw edema of mice. Life Sci. 58:1996;287-294.
16. Shiga Y., Onodera H., Matsuo Y., Kogure K. Cyclosporine-A protects against ischemia-reperfusion injury in the brain. Brain Res. 595:1992;145-148.
17. Snyder S.H., Sabatini D.M., Lai M.M., Steiner J.P., Hamilton G.S., Suzdak P.D. Neural actions of immunophilin ligands. Trends Pharmacol. Sci. 19:1998;21-26.
18. Steiner J.P., Connolly M.A., Valentine H.L., Hamilton G.S., Dawson T.M., Hester L., Snyder S.H. Neurotrophic actions of nonimmunosuppressive analogues of immunosuppressive drugs FK506, rapamycin and cyclosporin A. Nat. Med. 3:1997;421-428.
19. Tanaka T., Takeda M., Niigawa H., Hariguchi S., Nishimura T. Phosphorylated neurofilament accumulation in neuronal perikarya by cyclosporin A injection in rat brain. Methods Find. Exp. Clin. Pharmacol. 15:1993;77-87.
20. Uchino H., Elmer E., Uchino K., Li P.A., He Q.P., Smith M.L., Siesjo B.K. Amelioration by cyclosporin A of brain damage in transient forebrain ischemia in the rat. Brain Res. 812:1998;216-226.